UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 339

Sortiert nach

Hitchhiker's Guide to Super-Resolution: Introduction and Recent Advances

IEEE transactions on pattern analysis and machine intelligence, 2023-08, Vol.45 (8), p.9862-9882

2023

Volltextzugriff (PDF)

Impaired Responsiveness to the Platelet P2Y12 Receptor Antagonist Clopidogrel in Patients With Type 2 Diabetes and Coronary Artery Disease

Journal of the American College of Cardiology, 2014-09, Vol.64 (10), p.1005-1014

2014

Volltextzugriff (PDF)

Addendum to: Constraints on the quartic Higgs self-coupling from double-Higgs production at future hadron colliders

The journal of high energy physics, 2024-02, Vol.2024 (2), p.170-8, Article 170

2024

Volltextzugriff (PDF)

The Beauty and the Boost: A Higgs Boson Tale: Measurements of Higgs Boson Production at High Energy in Decays to Bottom Quarks and Their Interpretations with the ATLAS Experiment at the LHC

Moser, Brian

2023

Volltextzugriff (PDF)

Northern Goshawk Space Use and Resource Selection

The Journal of wildlife management, 2019-04, Vol.83 (3), p.705-713

2019

Volltextzugriff (PDF)

The Beauty and the Boost: Measurements of Higgs Boson Production at High Energy in Decays to Bottom Quarks and Their Interpretations with the ATLAS Experiment at the LHC

Moser, Brian

1, 2023

Volltextzugriff (PDF)

Prasugrel 5 mg in the Very Elderly Attenuates Platelet Inhibition But Maintains Noninferiority to Prasugrel 10 mg in Nonelderly Patients

Journal of the American College of Cardiology, 2013-08, Vol.62 (7), p.577-583

2013

Volltextzugriff (PDF)

A Phase Ib/II Study of Ramucirumab in Combination with Emibetuzumab in Patients with Advanced Cancer

Clinical cancer research, 2019-09, Vol.25 (17), p.5202-5211

2019

Volltextzugriff (PDF)

Assessment of immunogenicity from galcanezumab phase 3 trials in patients with episodic or chronic migraine

Cephalalgia, 2020-08, Vol.40 (9), p.978-989

2020

Volltextzugriff (PDF)

Prasugrel 5 mg in the Very Elderly Attenuates Platelet Inhibition But Maintains Noninferiority to Prasugrel 10 mg in Nonelderly Patients: The GENERATIONS Trial, A Pharmacodynamic and Pharmacokinetic Study in Stable Coronary Artery Disease Patients

Journal of the American College of Cardiology, 2013-08, Vol.62 (7), p.577-583

2013

Volltextzugriff (PDF)

The effect of CYP2C19 gene polymorphisms on the pharmacokinetics and pharmacodynamics of prasugrel 5-mg, prasugrel 10-mg and clopidogrel 75-mg in patients with coronary artery disease

Thrombosis and haemostasis, 2014, Vol.112 (3), p.589

2014

Volltextzugriff (PDF)

Population Pharmacokinetic and Exposure–Response Analyses of Prasugrel in Pediatric Patients with Sickle Cell Anemia

Clinical pharmacokinetics, 2018-02, Vol.57 (2), p.243-254

2018

Volltextzugriff (PDF)

Reduction in Platelet Reactivity With Prasugrel 5 mg in Low-Body-Weight Patients Is Noninferior to Prasugrel 10 mg in Higher-Body-Weight Patients

Journal of the American College of Cardiology, 2012-11, Vol.60 (20), p.2032-2040

2012

Volltextzugriff (PDF)

A first-in-human phase I trial of LY2780301, a dual p70 S6 kinase and Akt Inhibitor, in patients with advanced or metastatic cancer

Investigational new drugs, 2015-06, Vol.33 (3), p.710-719

2015

Volltextzugriff (PDF)

The influence of body size on the pharmacodynamic and pharmacokinetic response to clopidogrel and prasugrel: A retrospective analysis of the FEATHER study

Thrombosis research, 2014-09, Vol.134 (3), p.552-557

2014

Volltextzugriff (PDF)

Clopidogrel metaboliser status based on point-of-care CYP2C19 genetic testing in patients with coronary artery disease

Thrombosis and haemostasis, 2014, Vol.111 (5), p.943

2014

Volltextzugriff (PDF)

Higher body weight patients on clopidogrel maintenance therapy have lower active metabolite concentrations, lower levels of platelet inhibition, and higher rates of poor responders than low body weight patients

Journal of thrombosis and thrombolysis, 2014, Vol.38 (2), p.127-136

2014

Volltextzugriff (PDF)

Prasugrel in children with sickle cell disease: pharmacokinetic and pharmacodynamic data from an open-label, adaptive-design, dose-ranging study

Journal of pediatric hematology/oncology, 2015-01, Vol.37 (1), p.1-9

2015

Volltextzugriff (PDF)

Effects of Telemetry Location Error on Space-Use Estimates Using a Fixed-Kernel Density Estimator

The Journal of wildlife management, 2007-09, Vol.71 (7), p.2421-2426

2007

Volltextzugriff (PDF)

Anti–TGF-β1 Antibody Therapy in Patients with Diabetic Nephropathy

Journal of the American Society of Nephrology, 2017-03, Vol.28 (3), p.953-962

2017

Volltextzugriff (PDF)

Preparation and Evaluation of Multifunctional Branched Diesters As Fuel Property Enhancers for Biodiesel and Petroleum Diesel Fuels

Energy & fuels, 2014-05, Vol.28 (5), p.3262-3270

Moser, Bryan R

2014

Volltextzugriff (PDF)

Short-Term Effects of Timber Harvest and Weather on Northern Goshawk Reproduction in Northern Idaho

The Journal of raptor research, 2009-03, Vol.43 (1), p.1-10

2009

Volltextzugriff (PDF)

732 - EASI 90 response sustained up to 38 weeks after lebrikizumab withdrawal despite negligible serum concentrations

British journal of dermatology (1951), 2024-08, Vol.191 (Supplement_2)

2024

Volltextzugriff (PDF)

Genetic Variation in Metabolizing Enzyme and Transporter Genes: Comprehensive Assessment in 3 Major East Asian Subpopulations With Comparison to Caucasians and Africans

Journal of clinical pharmacology, 2010-08, Vol.50 (8), p.929-940

2010

Volltextzugriff (PDF)

1 – 25 von 339

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(278)
Mit Volltextzugriff
(296)

Publikationsform

4 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(192)
Life Sciences & Biomedicine
(139)
Humans
(117)
Female
(74)
Male
(72)
Aged
(50)
Middle Aged
(43)
Biological And Medical Sciences
(37)
Adult
(33)
Medical Sciences
(33)
Physical Sciences
(28)
Animals
(25)
Technology
(24)
Adolescent
(20)
Chemistry
(20)
Science & Technology - Other Topics
(20)
Neurosciences & Neurology
(19)
Environmental Sciences & Ecology
(18)
Multidisciplinary Sciences
(17)
Clinical Neurology
(16)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Journal Of The American College Of Cardiology
(10)
Biochemistry
(8)
Neurology
(5)
Plos One
(5)
Science
(5)
Biophysical Journal
(4)
Pharmaceutics
(4)
The Journal Of Physical Chemistry. B
(4)
Cancer Research
(3)
Chest
(3)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(3)
... seit 90 Tagen
(5)

Menü

Weitere Dienste

Einstellungen

Hitchhiker's Guide to Super-Resolution: Introduction and Recent Advances

Impaired Responsiveness to the Platelet P2Y12 Receptor Antagonist Clopidogrel in Patients With Type 2 Diabetes and Coronary Artery Disease

Addendum to: Constraints on the quartic Higgs self-coupling from double-Higgs production at future hadron colliders

The Beauty and the Boost: A Higgs Boson Tale: Measurements of Higgs Boson Production at High Energy in Decays to Bottom Quarks and Their Interpretations with the ATLAS Experiment at the LHC

Addition of ramucirumab or merestinib to standard first-line chemotherapy for locally advanced or metastatic biliary tract cancer: a randomised, double-blind, multicentre, phase 2 study

Northern Goshawk Space Use and Resource Selection

The Beauty and the Boost: Measurements of Higgs Boson Production at High Energy in Decays to Bottom Quarks and Their Interpretations with the ATLAS Experiment at the LHC

Prasugrel 5 mg in the Very Elderly Attenuates Platelet Inhibition But Maintains Noninferiority to Prasugrel 10 mg in Nonelderly Patients

A Phase Ib/II Study of Ramucirumab in Combination with Emibetuzumab in Patients with Advanced Cancer

Assessment of immunogenicity from galcanezumab phase 3 trials in patients with episodic or chronic migraine

Prasugrel 5 mg in the Very Elderly Attenuates Platelet Inhibition But Maintains Noninferiority to Prasugrel 10 mg in Nonelderly Patients: The GENERATIONS Trial, A Pharmacodynamic and Pharmacokinetic Study in Stable Coronary Artery Disease Patients

The effect of CYP2C19 gene polymorphisms on the pharmacokinetics and pharmacodynamics of prasugrel 5-mg, prasugrel 10-mg and clopidogrel 75-mg in patients with coronary artery disease

Population Pharmacokinetic and Exposure–Response Analyses of Prasugrel in Pediatric Patients with Sickle Cell Anemia

Reduction in Platelet Reactivity With Prasugrel 5 mg in Low-Body-Weight Patients Is Noninferior to Prasugrel 10 mg in Higher-Body-Weight Patients

A first-in-human phase I trial of LY2780301, a dual p70 S6 kinase and Akt Inhibitor, in patients with advanced or metastatic cancer

The influence of body size on the pharmacodynamic and pharmacokinetic response to clopidogrel and prasugrel: A retrospective analysis of the FEATHER study

Clopidogrel metaboliser status based on point-of-care CYP2C19 genetic testing in patients with coronary artery disease

Higher body weight patients on clopidogrel maintenance therapy have lower active metabolite concentrations, lower levels of platelet inhibition, and higher rates of poor responders than low body weight patients

Prasugrel in children with sickle cell disease: pharmacokinetic and pharmacodynamic data from an open-label, adaptive-design, dose-ranging study

Effects of Telemetry Location Error on Space-Use Estimates Using a Fixed-Kernel Density Estimator

Anti–TGF-β1 Antibody Therapy in Patients with Diabetic Nephropathy

Preparation and Evaluation of Multifunctional Branched Diesters As Fuel Property Enhancers for Biodiesel and Petroleum Diesel Fuels

Short-Term Effects of Timber Harvest and Weather on Northern Goshawk Reproduction in Northern Idaho

732 - EASI 90 response sustained up to 38 weeks after lebrikizumab withdrawal despite negligible serum concentrations

Genetic Variation in Metabolizing Enzyme and Transporter Genes: Comprehensive Assessment in 3 Major East Asian Subpopulations With Comparison to Caucasians and Africans

Suchergebnisse filtern